Dr. Heather Wakelee, Winston Chen and Phyllis Huang Professor,  is a Professor of Medicine and Chief of the Division of Oncology at Stanford University and Deputy Director of the Stanford Cancer Institute. Dr. Wakelee serves as the Past President of the International Association for the Study of Lung Cancer (IASLC) and is a Fellow of the American Society of Clinical Oncology (FASCO).  She is a graduate of Princeton University and Johns Hopkins University School of Medicine and completed her post-graduate training at Stanford University.  As an experienced lung cancer investigator, Dr. Wakelee has authored or co-authored over 300 medical articles on lung cancer and thymic malignancies and is involved in dozens of clinical trials involving adjuvant therapy, immunotherapy (particularly use of immunotherapy in the peri-operative setting for NSCLC), and anti-angiogenesis agents. Her research additionally is focused on many specific lung cancer subtypes defined by mutations in EGFR, ALK, ROS1, RET, BRAF and other relevant genes. Her translational efforts to date have involved collaborations with colleagues in medical oncology, thoracic radiation oncology, thoracic surgery, radiology, pulmonary medicine, and population sciences.